| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8653270 | Annals of Vascular Surgery | 2018 | 26 Pages |
Abstract
TEVAR is a safe approach in the treatment of BTAI associated with low short- and long-term morbidity and mortality rates. Lower age and SCA coverage may contribute to the development of postimplant hypertension. Further larger cohort studies are warranted to elucidate the underlying mechanisms of postimplant hypertension.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Konstantinos Tigkiropoulos, Fragiska Sigala, Diamantis I. Tsilimigras, Demetrios Moris, Konstantinos Filis, Nikolaos Melas, Dimitrios Karamanos, Christos Kontogiannis, Ioannis Lazaridis, Nikolaos Saratzis,